Radicle PerformanceTM VKN: A Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes

ConditionFatigue
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-60
SponsorRadicle Science

About this trial

Radicle Performance™ VKN: A randomized, double-blind, placebo controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related health outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults, aged 35-60 at the time of electronic consent, inclusive of all ethnicities, races, and gender identities

Assigned sex at birth will determine sex-specific recruitment and PROs (male vs female) employed, when needed

Experiencing fatigue and/or perceiving a decline in sports performance due to tiredness

Resides in the United States

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Placebo Health Performance Control

    Dietary supplement

    Participants will use their Placebo Health Performance Control as directed for a period of 4 weeks

  • Active Health Performance Product

    Dietary supplement

    Participants will use their Active Health Performance Product as directed for a period of 4 weeks

Treatment groups

650 Participants
are divided into 2 treatment groups
Group A: Active Health Performance Product 1Experimental treatment 1 intervention
Group B: Placebo Health Performance ControlPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in fatigue

Fatigue score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 8A (scale 8-40; where higher scores correspond to more severe fatigue)

Time frame
5 weeks

Secondary outcomes

1

Change in sleep

Sleep score as assessed by PROMIS Sleep Disturbance 8A (scale 8-40; where higher scores correspond to higher levels of sleep disturbance)

Time frame
5 weeks
2

Change in feelings of stress

Stress score as assessed Perceived Stress Scale 4 (PSS-4) (scale 0-16; where lower scores correspond to less stress)

Time frame
5 weeks

Other outcomes

1

Minimal clinically important difference (MCID) in fatigue

Minimal clinically important difference (MCID) in fatigue: Likelihood of experiencing minimal clinically important difference in fatigue score as assessed by PROMIS Fatigue 8A (scale 8-40; where higher scores correspond to more severe fatigue)

Time frame
5 weeks
2

Minimal clinically important difference (MCID) in sleep

Minimal clinically important difference (MCID) in sleep: Likelihood of experiencing minimal clinically important difference in sleep score as assessed by PROMIS Sleep Disturbance 8A (scale 8-40; where higher scores correspond to higher levels of sleep disturbance)

Time frame
5 weeks
3

Minimal clinically important difference (MCID) in feelings of stress

Minimal clinically important difference (MCID) in feelings of stress: Likelihood of experiencing minimal clinically important difference in feelings of stress as assessed by Perceived Stress Scale (PSS-4) (scale 0-16; where lower scores correspond to less stress)

Time frame
5 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: